Thomas J. Tarlow

Consigliere Generale presso Talon Therapeutics, Inc.

Health Technology

Consumer Services

Profilo

Thomas J.
Tarlow is currently working as the Vice President-Regulatory Affairs & Quality at Talon Therapeutics, Inc. since 2009.
Previously, he worked at Tercica, Inc. as the VP-Regulatory Affairs & Document Archives.
He holds a graduate degree from the University of California, Davis and an undergraduate degree from the University of California, Santa Cruz.

Posizioni attive di Thomas J. Tarlow

Società	Posizione	Inizio
Talon Therapeutics, Inc. Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.	Consigliere Generale	01/01/2009

Tutte le posizioni attive di Thomas J. Tarlow

Precedenti posizioni note di Thomas J. Tarlow

Società	Posizione	Fine
Tercica, Inc. Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc.	Consigliere Generale	-

Vedi nel dettaglio l'esperienza di Thomas J. Tarlow

Formazione di Thomas J. Tarlow

University of California, Davis	Graduate Degree
University of California, Santa Cruz	Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Thomas J. Tarlow

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	2
Talon Therapeutics, Inc. Talon Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Talon Therapeutics, Inc. is a biopharmaceutical company, which is engaged in the developing and commercializing new and differentiated cancer therapies. The firm is developing the Marqibo for the treatment of acute lymphoblastic leukemia and other blood cancers including lymphoma. Its Menadione topical lotion is a compound which is developed for the prevention and treatment of skin toxicity associated with epidermal growth factor receptor inhibitors. The company was founded by Mark J. Ahn in 2002 and is headquartered in San Mateo, CA.	Health Technology
Tercica, Inc. Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc.	Health Technology